drugset / Trial / NCT00399269
Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To establish the efficacy and Safety of rHu-EPO-alpha in patients with anemia of Chronic Renal Failure.
Timeline
- Start
- 2006-12
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Human Erythropoietin Alpha | Protein / enzyme biologic | — | — |